Form 4: Lemaitre Vascular Director Exercises Options and Sells Shares
SEC Form 4 Filing
Director Bridget A. Ross exercised stock options and sold shares of Lemaitre Vascular Inc. on May 16, 2024.
Summary
- On May 16, 2024, Bridget A. Ross, a director of Lemaitre Vascular Inc., exercised stock options to acquire 5,500 shares of common stock at a price of $30 per share.
- Simultaneously, Ross sold 5,500 shares of common stock at a price of $77.99 per share.
- Following these transactions, Ross directly owns 2,278 shares of common stock and 7,500 stock options.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, disclosing insider transactions. Such filings are common and provide transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 04/28/2020 | Date of grant for the stock options, vesting over three years. |
| 05/16/2024 | Date of the transaction: exercise of options and sale of shares. |
| 04/28/2025 | Expiration date of the stock options. |
| 05/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.